Bafna Pharmaceuticals Ltd Board of Directors
Board of Directors at Bafna Pharmaceuticals Ltd
Company Sec. & Compli. Officer
Non-Exec & Non-Independent Dir
Non-Exec. & Independent Dir.
Independent Director
Non-Exec. & Independent Dir.
Key Highlights
- Ravichandran Chitra joins the board as Chairperson, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Shanmugam Hemalatha continues to serve as the E D & Wholetime Director in 2026, maintaining the same position as in the previous year.
- Vinayak Dinesh Dendukuri joins the board as ED / WTD - Quality, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Akilapriya Chandrashekar Raju joins the board as Non-Exec & Non-Independent Dir, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Upendar Mekala Reddy continues to serve as the Non-Exec & Non-Independent Dir in 2026, maintaining the same position as in the previous year.
Bafna Pharmaceuticals Ltd
NSE: BAFNAPH
Share Price
Last Ten Days Market Price
| Date | |
|---|---|
| 06 Oct 2026 | 400.55 |
| 05 Oct 2026 | 392.7 |
| 01 Oct 2026 | 385 |
| 30 Sep 2026 | 377.7 |
| 29 Sep 2026 | 370.3 |
| 28 Sep 2026 | 363.05 |
| 25 Sep 2026 | 355.95 |
| 24 Sep 2026 | 349 |
| 23 Sep 2026 | 342.2 |
| 22 Sep 2026 | 335.5 |
Company Fundamentals for Bafna Pharmaceuticals Ltd
Market Cap
947 Cr
EPS
3.3
P/E Ratio (TTM)
121.8
P/B Ratio (TTM)
9.9
Day’s High
400.55
Day’s Low
400.55
DTE
0.4
ROE
11.5
52 Week High
400.55
52 Week Low
95.0
ROCE
10.6
Market Price of Bafna Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Bafna Pharmaceuticals Ltd News Hub
Bafna Pharmaceuticals reports standalone net loss of Rs 0.72 crore in the June 2024 quarter
Net loss of Bafna Pharmaceuticals reported to Rs 0.72 crore in the quarter ended June 2024 as agains
Read more
13 Aug 24
Bafna Pharmaceuticals to declare Quarterly Result
Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 2024
Read more
10 Aug 24
Bafna Pharmaceuticals to convene AGM
Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on
Read more
04 Sept 24
Bafna Pharmaceuticals schedules AGM
Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on
Read more
05 Sept 24
